These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7857380)
1. The dyslipoproteinemias of diabetes. Steiner G Atherosclerosis; 1994 Oct; 110 Suppl():S27-33. PubMed ID: 7857380 [TBL] [Abstract][Full Text] [Related]
2. Dyslipoproteinemias in diabetes. Steiner G Clin Invest Med; 1995 Aug; 18(4):282-7. PubMed ID: 8549014 [TBL] [Abstract][Full Text] [Related]
3. Diabetes, lipoproteins, and atherosclerosis. Schonfeld G Metabolism; 1985 Dec; 34(12 Suppl 1):45-50. PubMed ID: 3906360 [TBL] [Abstract][Full Text] [Related]
4. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus]. Fábryová L; Cagán S Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742 [TBL] [Abstract][Full Text] [Related]
5. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Colwell JA; Winocour PD; Lopes-Virella M; Halushka PV Am J Med; 1983 Nov; 75(5B):67-80. PubMed ID: 6424441 [TBL] [Abstract][Full Text] [Related]
11. The plasma lipoproteins: current concepts of metabolism and structure with clinical implications. Gotto AM Adv Exp Med Biol; 1978; 104():61-76. PubMed ID: 213956 [No Abstract] [Full Text] [Related]
14. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Eisenberg S Am Heart J; 1987 Feb; 113(2 Pt 2):555-61. PubMed ID: 3544770 [No Abstract] [Full Text] [Related]
16. [Insulin-dependent diabetes and lipoprotein metabolism]. Berthezène F; Perrot L; Valentin C; Sautot G Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527 [No Abstract] [Full Text] [Related]
17. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. Goff DC; D'Agostino RB; Haffner SM; Saad MF; Wagenknecht LE Diabetes Care; 2000 Jul; 23(7):1006-11. PubMed ID: 10895855 [TBL] [Abstract][Full Text] [Related]
18. Lipoproteins, cholesterol ester transport and atherogenesis. Eisenberg S Monogr Atheroscler; 1986; 14():107-12. PubMed ID: 3736547 [No Abstract] [Full Text] [Related]
19. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Lewis GF; Steiner G Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500 [No Abstract] [Full Text] [Related]
20. Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy. Eisenberg S Adv Exp Med Biol; 1985; 183():73-84. PubMed ID: 4036705 [No Abstract] [Full Text] [Related] [Next] [New Search]